FDA Approval Was Granted For a Duchenne Muscular Dystrophy Drug Amid Internal Disagreements
The accelerated approval granted by the FDA for the Duchenne muscular dystrophy drug eteplirsen, developed by Sarepta Therapeutics, was granted only after internal disagreements and protests had been resolved.…